Mylan, Cephalon Spar In Fed. Circ. Over Amrix MDL Ruling
Mylan Pharmaceuticals Inc. and Cephalon Inc. clashed before the Federal Circuit on Wednesday over whether the two patents in the multidistrict litigation over Cephalon's drug Amrix were infringed or invalid for...To view the full article, register now.
Already a subscriber? Click here to view full article